Midwest Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Midwest Trust's AZN Position: Q3 2026 in Review
Midwest Trust increased its AstraZeneca (AZN) stake by 51% in Q3 2026, buying an estimated $264K and bringing the position to 4,698 shares worth $759K. The position accounts for 0.01% of the portfolio, ranked #402.
Midwest Trust first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. 479 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Midwest Trust held 4,698 shares of AstraZeneca worth $759K as of Q3 2026.
- Midwest Trust bought 1,585 AstraZeneca shares in Q3 2026, an estimated $264K.
- AstraZeneca made up 0.01% of Midwest Trust's portfolio in Q3 2026, its #402 holding.
- Midwest Trust first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
- 479 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.